William Phillips, MD, discusses real-world findings on RET inhibitor dose reductions and clinical outcomes in advanced RET fusion–positive NSCLC.
William Phillips, MD
Advertisement
Articles by William Phillips, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
Early mRNA Vaccine Data Excite Possibilities of Long-Term PDAC Remissions
2
FDA Flashback: GI Cancer Decisions and News From July 2026
3
TNFR2 Advances as a Novel Target for Restoring Antitumor Immunity Across Lymphoma and Solid Tumors
4
FDA Advisory Committee to Review Premarket Approval Application for Multi-Cancer Early Detection Test
5